Vas Healthcare, a developer of vascular interventional surgery robots based in Beijing, has reportedly raised RMB 100 million (USD 14.5 million) in an angel financing round. The round was co-led by CAS Investment and Noah Capital. The funds will be used to support technology research and development, new product iteration, team development, and market promotion, among other areas.
Innovative Product and Market Entry
Vas Healthcare’s in-house developed vascular interventional surgery robot was approved for marketing in China this month, marking it as the first “auxiliary operation system for cerebral vascular intervention surgery” in the country. This milestone underscores the company’s commitment to innovation in the field of medical robotics.
Future Plans and Technological Advancements
Looking ahead, Vas Healthcare will explore and implement cutting-edge technologies such as multimodal image data fusion navigation and artificial intelligence (AI)-enabled automatic path planning. The company also plans to launch its surgical simulation cabin, VAS COACH, which will further enhance its market presence and capabilities in vascular interventional surgery.-Fineline Info & Tech
